These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28259993)

  • 1. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
    Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
    Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting glycometabolic reprogramming to restore the sensitivity of leukemia drug-resistant K562/ADM cells to adriamycin.
    Zhang X; Chen J; Ai Z; Zhang Z; Lin L; Wei H
    Life Sci; 2018 Dec; 215():1-10. PubMed ID: 30473023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.
    Sun Y; Chen Y; Xu M; Liu C; Shang H; Wang C
    Biomed Res Int; 2020; 2020():9243681. PubMed ID: 32685545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells.
    Zheng J; Asakawa T; Chen Y; Zheng Z; Chen B; Lin M; Liu T; Hu J
    Cell Physiol Biochem; 2017; 43(1):419-430. PubMed ID: 28869936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine reverses the drug resistance of leukemic K562/ADM cells by inhibiting autophagy.
    Wang F; Zhang Z; Leung WT; Chen J; Yi J; Ying C; Yuan M; Wang M; Zhang N; Qiu X; Wang L; Wei H
    Mol Med Rep; 2019 Oct; 20(4):3883-3892. PubMed ID: 31485616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells.
    Zhang X; Ai Z; Zhang Z; Dong R; Wang L; Jin S; Wei H
    DNA Cell Biol; 2022 Aug; 41(8):705-715. PubMed ID: 35687364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy.
    Cheng J; Chen J; Xie B; Wei HL
    Toxicol Mech Methods; 2013 Nov; 23(9):678-83. PubMed ID: 24024664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling.
    Wang L; Chen B; Lin M; Cao Y; Chen Y; Chen X; Liu T; Hu J
    Immunobiology; 2015 Mar; 220(3):331-40. PubMed ID: 25457413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.
    Wang L; Wang C; Jia Y; Liu Z; Shu X; Liu K
    J Cell Biochem; 2016 May; 117(5):1233-9. PubMed ID: 26460589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y; Zhao Y; Guo L
    Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
    Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
    Liu L; Zhang M; Zou P; Tian L; Liu F
    Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osthole shows the potential to overcome P-glycoprotein‑mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Wang JY; Li YJ
    Oncol Rep; 2016 Jun; 35(6):3659-68. PubMed ID: 27109742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.